FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366606614> ?p ?o ?g. }

• W4366606614 endingPage "154825" @default.
• W4366606614 startingPage "154825" @default.
• W4366606614 abstract "Allergic rhinitis (AR) defined as inflammation and tissue remodeling of the nasal mucosa in atopic individuals after allergen exposure. Alpha-linolenic acid [cis-9, cis-12, cis-15-octadecatrienoic acid (18:3)] (ALA) as dietary supplementation can reduce inflammation and allergic symptoms. To evaluate the potential therapeutic effect and mechanism of ALA in AR mouse model. Ovalbumin sensitized AR mouse model were challenged with oral ALA administration. Nasal symptoms, tissue pathology, immune cell infiltration and goblet cell hyperplasia were investigated. Levels of IgE, TNF-β, IFN-γ, IL-2, IL-4, IL-5, IL-12, IL-13 and IL-25 were determined by ELISA in serum and nasal fluid. Quantitative RT-PCR and immunofluorescence were performed for occludin and zonula occludens-1 expression. CD3+CD4+ T-cells from peripheral blood and splenic lymphocytes were isolated and Th1/Th2 ratio were determined. Mouse naive CD4+ T cell were isolated and Th1/Th2 ratio, IL-4Rα expression, and IL5/IL13 secretion were determined. IL-4Rα-JAK2-STAT3 pathway change in AR mice were performed by western blot. Ovalbumin induced AR, nasal symptoms, pathological performance, IgE, and cytokine production. ALA treated mice showed reduced nasal symptoms, nasal inflammation, nasal septum thickening, goblet cell hyperplasia, and eosinophil infiltration. In serum and nasal fluid of ovalbumin challenged mice, ALA decreased IgE, IL-4 levels, and the increase of Th2-cells. ALA prevented the disruption of the epithelial cell barrier in ovalbumin-challenged AR mice. Simultaneously, ALA prevents IL-4 induced barrier disruption. ALA treatment of AR by affecting the differentiation stage of CD4+T cells and block IL-4Rα-JAK2-STAT3 pathway. This study suggests that ALA has the potential therapeutic effect to ovalbumin-induced AR. ALA can affect the differentiation stage of CD4+T cells and improve epithelial barrier functions through IL-4Rα-JAK2-STAT3 pathways. ALA might be considered as drug candidate for improving epithelial barrier function through Th1/Th2 ratio recovery in AR." @default.
• W4366606614 created "2023-04-23" @default.
• W4366606614 creator A5000757975 @default.
• W4366606614 creator A5005694036 @default.
• W4366606614 creator A5008096141 @default.
• W4366606614 creator A5014954540 @default.
• W4366606614 creator A5035701638 @default.
• W4366606614 creator A5056115836 @default.
• W4366606614 creator A5065826315 @default.
• W4366606614 creator A5078132522 @default.
• W4366606614 creator A5087266438 @default.
• W4366606614 creator A5089903476 @default.
• W4366606614 date "2023-07-01" @default.
• W4366606614 modified "2023-10-17" @default.
• W4366606614 title "Alpha-linolenic acid improves nasal mucosa epithelial barrier function in allergic rhinitis by arresting CD4+ T cell differentiation via IL-4Rα-JAK2-STAT3 pathway" @default.
• W4366606614 cites W1489307431 @default.
• W4366606614 cites W1842518224 @default.
• W4366606614 cites W1932880974 @default.
• W4366606614 cites W1980059877 @default.
• W4366606614 cites W1993734178 @default.
• W4366606614 cites W2000422049 @default.
• W4366606614 cites W2003099988 @default.
• W4366606614 cites W2007787730 @default.
• W4366606614 cites W2009993815 @default.
• W4366606614 cites W2034000631 @default.
• W4366606614 cites W2053321569 @default.
• W4366606614 cites W2055063698 @default.
• W4366606614 cites W2056448247 @default.
• W4366606614 cites W2063575668 @default.
• W4366606614 cites W2063748338 @default.
• W4366606614 cites W2064320740 @default.
• W4366606614 cites W2065997245 @default.
• W4366606614 cites W2067352199 @default.
• W4366606614 cites W2071294129 @default.
• W4366606614 cites W2095499340 @default.
• W4366606614 cites W2110465069 @default.
• W4366606614 cites W2140410130 @default.
• W4366606614 cites W2161762907 @default.
• W4366606614 cites W2165098074 @default.
• W4366606614 cites W2187498693 @default.
• W4366606614 cites W2263441890 @default.
• W4366606614 cites W2266684950 @default.
• W4366606614 cites W2343444323 @default.
• W4366606614 cites W2368044794 @default.
• W4366606614 cites W2400892638 @default.
• W4366606614 cites W2429860870 @default.
• W4366606614 cites W2502641688 @default.
• W4366606614 cites W2765934505 @default.
• W4366606614 cites W2768882109 @default.
• W4366606614 cites W2773248196 @default.
• W4366606614 cites W2777757515 @default.
• W4366606614 cites W2809132731 @default.
• W4366606614 cites W2901606332 @default.
• W4366606614 cites W2916610774 @default.
• W4366606614 cites W2990165661 @default.
• W4366606614 cites W3016897056 @default.
• W4366606614 cites W657518852 @default.
• W4366606614 doi "https://doi.org/10.1016/j.phymed.2023.154825" @default.
• W4366606614 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37178572" @default.
• W4366606614 hasPublicationYear "2023" @default.
• W4366606614 type Work @default.
• W4366606614 citedByCount "0" @default.
• W4366606614 crossrefType "journal-article" @default.
• W4366606614 hasAuthorship W4366606614A5000757975 @default.
• W4366606614 hasAuthorship W4366606614A5005694036 @default.
• W4366606614 hasAuthorship W4366606614A5008096141 @default.
• W4366606614 hasAuthorship W4366606614A5014954540 @default.
• W4366606614 hasAuthorship W4366606614A5035701638 @default.
• W4366606614 hasAuthorship W4366606614A5056115836 @default.
• W4366606614 hasAuthorship W4366606614A5065826315 @default.
• W4366606614 hasAuthorship W4366606614A5078132522 @default.
• W4366606614 hasAuthorship W4366606614A5087266438 @default.
• W4366606614 hasAuthorship W4366606614A5089903476 @default.
• W4366606614 hasConcept C141105273 @default.
• W4366606614 hasConcept C142724271 @default.
• W4366606614 hasConcept C159654299 @default.
• W4366606614 hasConcept C185592680 @default.
• W4366606614 hasConcept C203014093 @default.
• W4366606614 hasConcept C2775941134 @default.
• W4366606614 hasConcept C2776042228 @default.
• W4366606614 hasConcept C2776914184 @default.
• W4366606614 hasConcept C2776946954 @default.
• W4366606614 hasConcept C2777037409 @default.
• W4366606614 hasConcept C2778690821 @default.
• W4366606614 hasConcept C2779675166 @default.
• W4366606614 hasConcept C32046619 @default.
• W4366606614 hasConcept C529295009 @default.
• W4366606614 hasConcept C59377437 @default.
• W4366606614 hasConcept C71924100 @default.
• W4366606614 hasConcept C74172505 @default.
• W4366606614 hasConcept C8891405 @default.
• W4366606614 hasConceptScore W4366606614C141105273 @default.
• W4366606614 hasConceptScore W4366606614C142724271 @default.
• W4366606614 hasConceptScore W4366606614C159654299 @default.
• W4366606614 hasConceptScore W4366606614C185592680 @default.
• W4366606614 hasConceptScore W4366606614C203014093 @default.
• W4366606614 hasConceptScore W4366606614C2775941134 @default.
• W4366606614 hasConceptScore W4366606614C2776042228 @default.

• next